Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Reed

Showing results (111-120 of 358) with videos related to

Pageof 36
Sort By:
The Journal of Biological Chemistry|October 16, 2004
Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming regionMounia Chami, Andrea Prandini, Michelangelo Campanella, et al.
Molecular Cancer Therapeutics|June 21, 2008
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsDayong Zhai, Chaofang Jin, Chung-Wai Shiau, et al.
Journal of Neurotrauma|June 14, 2003
Temporal alterations in cellular Bax:Bcl-2 ratio following traumatic brain injury in the ratRamesh Raghupathi, Kenneth I Strauss, Chen Zhang, et al.
Molecular and Cellular Biology|September 27, 2006
Regulation of p53 localization and activity by Ubc13Aaron Laine, Ivan Topisirovic, Dayong Zhai, et al.
Genesis (New York, N.Y. : 2000)|April 14, 2005
Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous systemSteven Banares, Karin Zeh, Maryla Krajewska, et al.
FEBS Letters|February 20, 2002
Induction of mammalian cell death by a plant Bax inhibitorLi Hua Yu, Maki Kawai-Yamada, Mikihiko Naito, et al.
The Journal of Biological Chemistry|November 12, 2005
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspasesTemesgen Samuel, Kate Welsh, Thomas Lober, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activation pathwayKarl J Okolotowicz, Ranxin Shi, Xueying Zheng, et al.
Blood|December 17, 2008
Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancerJuan M Zapata, David Llobet, Maryla Krajewska, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2009
Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerizationBenjamin Faustin, Ya Chen, Dayong Zhai, et al.
Pageof 36

Showing results (111-120 of 358) with videos related to

Sort By:
Pageof 36
The Journal of Biological Chemistry|October 16, 2004
Bcl-2 and Bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming regionMounia Chami, Andrea Prandini, Michelangelo Campanella, et al.
Molecular Cancer Therapeutics|June 21, 2008
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsDayong Zhai, Chaofang Jin, Chung-Wai Shiau, et al.
Journal of Neurotrauma|June 14, 2003
Temporal alterations in cellular Bax:Bcl-2 ratio following traumatic brain injury in the ratRamesh Raghupathi, Kenneth I Strauss, Chen Zhang, et al.
Molecular and Cellular Biology|September 27, 2006
Regulation of p53 localization and activity by Ubc13Aaron Laine, Ivan Topisirovic, Dayong Zhai, et al.
Genesis (New York, N.Y. : 2000)|April 14, 2005
Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous systemSteven Banares, Karin Zeh, Maryla Krajewska, et al.
FEBS Letters|February 20, 2002
Induction of mammalian cell death by a plant Bax inhibitorLi Hua Yu, Maki Kawai-Yamada, Mikihiko Naito, et al.
The Journal of Biological Chemistry|November 12, 2005
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspasesTemesgen Samuel, Kate Welsh, Thomas Lober, et al.
Bioorganic & Medicinal Chemistry|February 16, 2010
Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activation pathwayKarl J Okolotowicz, Ranxin Shi, Xueying Zheng, et al.
Blood|December 17, 2008
Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancerJuan M Zapata, David Llobet, Maryla Krajewska, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2009
Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerizationBenjamin Faustin, Ya Chen, Dayong Zhai, et al.
Pageof 36